Biogenic Reagents
Renewable, high-performance biocarbon for purification and energy
About Biogenic Reagents
Biogenic Reagents specialized in producing high-performance carbon products derived from renewable biomass, positioning them as cleaner, lower-cost, and better-performing alternatives to traditional coal-based carbons. The company developed an advanced, proprietary pyrolysis technology to convert sustainably sourced wood feedstock into valuable carbon products. Its product portfolio included activated carbons for air and water purification, metallurgical carbons for iron and metals production, and thermal carbons for energy generation.
A key application for Biogenic Reagents' products was mercury emissions control from power plants. Their activated carbon, injected into the gas stream, could reduce mercury emissions by over 90%. In 2013, the company began commercial production of a graphene-carbon compound called Ultra-Adsorptive Carbon (UAC), which demonstrated a 50% greater adsorptive capacity than coal-based activated carbon. By 2015, its water purification product, UAC-H20, had been adopted by over 50 municipalities across North America.
The company was led by CEO James Mennell, who has experience in over 50 renewable energy projects. Key innovators included Chief Technology Officer Dan Despen and Steve Filips, who are listed as inventors on patents for high-carbon biogenic reagents. In 2012, the firm initiated commercial production at a $30 million facility in Marquette, Michigan. It secured a $9.5 million investment from MVC Capital in 2013 to expand reactor capacity. In 2014, Biogenic Reagents formed a joint venture with West Fraser, North America's largest lumber producer, to create Biogenic Reagents Ventures LLC for developing new renewable biocarbon products. However, some sources indicate the company may no longer be in business.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- Minneapolis, United States
News
Open roles
Biogenic Reagents in the Minneapolis ecosystem
The Biogenic Reagents office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- MCMVC Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biogenic Reagents on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biogenic Reagents on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.